Position in GILD
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$25,235,151
-$2,952,849 QoQ
Shares Held
199,740
-1.2% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.28%
of 13F equity value
Holder Rank
#295
of 2,266 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BANQUE PICTET & CIE SA holds $370,874,778 across 8 Drug Manufacturers - General names. GILD ranks #6 (6.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
409,324 | $103,002,291 | |
| 2 | LLY |
ELI LILLY & Co
|
67,095 | $80,475,762 | |
| 3 | MRK |
Merck & Co., Inc.
|
503,429 | $64,690,626 | |
| 4 | JNJ |
Johnson & Johnson
|
173,057 | $43,951,286 | |
| 5 | AZN |
Astrazeneca PLC
|
186,686 | $35,399,399 | |
| 6 | GILD |
Gilead Sciences, Inc.
This page
|
199,740 | $25,235,151 | |
| 7 | BIIB |
Biogen Inc.
|
65,080 | $14,061,184 | |
| 8 | NVO |
Novo Nordisk A S
|
84,670 | $4,059,079 |
All Filings in GILD
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $25,235,151 | 199,740 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $28,188,000 | 202,253 | Shares | Sole | 2026-04-14 | |
| 2025-12-31 | $27,862,839 | 227,007 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $9,375,504 | 84,464 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $8,269,349 | 74,586 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $4,140,583 | 36,953 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $4,768,231 | 51,621 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $461,120 | 5,500 | Shares | Sole | 2024-10-21 | |
| 2024-06-30 | $377,355 | 5,500 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $402,875 | 5,500 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $445,555 | 5,500 | Shares | Sole | 2024-02-09 | |
| 2023-06-30 | $896,169 | 11,628 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $1,039,697 | 12,531 | Shares | Sole | 2023-05-01 | |
| 2022-12-31 | $1,320,802 | 15,385 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $1,128,433 | 18,292 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $1,694,953 | 27,422 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $4,596,376 | 77,315 | Shares | Sole | 2022-05-04 | |
| 2021-06-30 | $2,945,555 | 42,776 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $2,958,502 | 45,776 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $3,462,158 | 59,426 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $3,904,510 | 61,790 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $5,184,986 | 67,390 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $5,776,779 | 77,271 | Shares | Sole | 2020-04-30 | |
| No filing history on record for this holder in this stock. | ||||||